BioRegenx Files Amended 2024 10-K with Equity Revisions
Ticker: BRGX · Form: 10-K/A · Filed: Apr 16, 2025 · CIK: 1593184
| Field | Detail |
|---|---|
| Company | Bioregenx, INC. (BRGX) |
| Form Type | 10-K/A |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-reporting, equity
TL;DR
BioRegenx amended its 2024 10-K, fixing equity details. Check the numbers!
AI Summary
BioRegenx, Inc. filed an amended 10-K for the fiscal year ending December 31, 2024, on April 16, 2025. The filing includes revised financial statements, specifically the Statement of Equity, detailing changes in common stock, preferred stock, additional paid-in capital, and retained earnings for the years 2023 and 2024. The company was formerly known as FindIt, Inc. and Artemis Energy Holdings, Inc.
Why It Matters
This amendment provides updated and potentially corrected financial details regarding the company's equity structure, which is crucial for investors to accurately assess the company's financial health and ownership.
Risk Assessment
Risk Level: medium — Amendments to SEC filings can indicate errors or restatements, requiring careful review by investors to understand the implications.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the amended 10-K)
- 2023-12-31 — Prior Year End (Comparative financial data)
- 20210219 — Name Change Date (Date BioRegenx changed from FindIt, Inc.)
Key Players & Entities
- BIOREGENX, INC. (company) — Filer
- FINDIT, INC. (company) — Former company name
- ARTEMIS ENERGY HOLDINGS, INC. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250416 (date) — Filing date
FAQ
What specific financial statement was revised in this 10-K/A filing?
The filing specifically revises the Statement of Equity for BioRegenx, Inc.
What was BioRegenx, Inc. previously named?
BioRegenx, Inc. was formerly known as FindIt, Inc. and prior to that, Artemis Energy Holdings, Inc.
On what date was this amended 10-K filed?
This amended 10-K (10-K/A) was filed on April 16, 2025.
What fiscal year does this amended filing cover?
This amended 10-K filing covers the fiscal year ending December 31, 2024.
What types of equity are detailed in the Statement of Equity revisions?
The Statement of Equity revisions detail changes in Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 16, 2025 regarding BIOREGENX, INC. (BRGX).